1. Assessment of Puberty and Hypothalamic--Pituitary--Gonadal Axis Function After Childhood Brain Tumor Treatment.
- Author
-
Rosimont, Manon, Kariyawasam, Dulanjalee, Samara-Boustani, Dinane, Giani, Elisa, Beltrand, Jacques, Bolle, Stephanie, Fresneau, Brice, Puget, Stephanie, Sainte-Rose, Christian, Alapetite, Claire, Pinto, Graziella, Touraine, Philippe, Piketty, Marie-Liesse, Brabant, Séverine, Abbou, Samuel, Aerts, Isabelle, Beccaria, Kevin, Bourgeois, Marie, Roujeau, Thomas, and Blauwblomme, Thomas
- Subjects
PUBERTY ,HYPOTHALAMUS ,BRAIN tumors - Abstract
Context: Endocrine complications are common in pediatric brain tumor patients. Objective: To describe hypothalamic--pituitary--gonadal axis (HPGA) function in patients treated in childhood for a primary brain tumor more than 5 years earlier, in order to identify risk factors for HPGA impairment. Methods: We retrospectively included 204 patients diagnosed with a primary brain tumor before 18 years of age and monitored at the pediatric endocrinology unit of the Necker Enfants-Malades University Hospital (Paris, France) between January 2010 and December 2015. Patients with pituitary adenoma or untreated glioma were excluded. Results: Among patients with suprasellar glioma not treated by radiotherapy, the prevalence of advanced puberty was 65% overall and 70% when the diagnosis occurred before 5 years of age. Medulloblastoma chemotherapy caused gonadal toxicity in 70% of all patients and in 87.5% of those younger than 5 years at diagnosis. In the group with craniopharyngioma, 70% of patients had hypogonadotropic hypogonadism, which was consistently accompanied by growth hormone deficiency. Conclusion: Tumor type, location, and treatment were the risk main factors for HPGA impairment. Awareness that onset can be delayed is essential to guide information of parents and patients, patient monitoring, and timely hormone replacement therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF